IRADIMED CORP - Common Stock (IRMD)

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
2,656,786
Share change
+90,141
Total reported value
$54,328,507
Price per share
$20.45
Number of holders
51
Value change
+$717,022
Number of buys
26
Number of sells
27

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2019

As of 30 Jun 2019, IRADIMED CORP - Common Stock (IRMD) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,656,786 shares. The largest 10 holders included BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Ranger Investment Management, L.P., RK Capital Management, LLC, Mondrian Investment Partners LTD, Navellier & Associates Inc, CADENCE CAPITAL MANAGEMENT LLC, MARSHALL WACE, LLP, and NORTHERN TRUST CORP. This page lists 51 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.